6. årlige ECD Medical Symposium Orlando, FL

Xavier Solanich, MD, PHD
Orlando Regional Medical Center
Orlando, FL
1. april 2018

Orlando Medical Symposium gruppebilde 2018

Sammendrag av symposiet

Omtrent 44 medisinske fagfolk fra seks land deltok på det årlige ECD medisinske symposiumet i 2018. Ti muntlige sammendrag ble presentert, sammen med ytterligere seks posterpresentasjoner. Som invitert foredragsholder holdt Matthew Collin et foredrag med tittelen «Erdheim-Chester sykdom: Kreft, men ikke slik vi kjenner den». En kveldsresepsjon ga tid til diskusjoner som støttet nåværende og fremtidige samarbeid blant denne svært kunnskapsrike gruppen av leger og forskere, alle interessert i å lære mer om Erdheim-Chester sykdom.

Deltakernes opplevelser

«[ECD Global Alliance] har hjulpet meg og mine pasienter ved å] samle eksperter for å oppnå samarbeidende fremgang.»

– Ronald S. Go, MD, deltaker 2018

Programmer med agenda for symposiet

Presentasjoner

PresenterPresentation SlidesEnglish Video
Julio Hajdenberg, MDWelcome AddressNot Available
Matthew Collin, MD, PhDErdheim Chester Disease: Cancer, but not as we know it.Not Available
Eli L. Diamond, MDPatient-reported outcomes in adults with Erdheim-Chester Disease: Early findings from the ECD RegistryNot Available
Benjamin Durham, MDNovel Activating Mutations in CSF1R and Additional Receptor Tyrosine Kinases in Histiocytic NeoplasmsNot Available
Ran Weissman, M.ScThe role of microRNAs in the Pathogenesis of Erdheim-Chester Disease and their Potential Use as Biomarkers for Diagnosis and Prognosis of the DiseaseNot Available
Julien Haroche, MD, PhDSlide deck not availableImaging aspect of cardiac involvement in Erdheim-Chester disease: cardiac CT and MRI of 188 patients
Gaurav Goyal, MDTumor mutational burden and other immunotherapy markers in Erdheim-Chester disease and other histiocytic neoplasmsTumor mutational burden and other immunotherapy markers in Erdheim-Chester disease and other histiocytic neoplasms
Anaïs Roeser, MDAuto-immunity in L-group histiocytosesAuto-immunity in L-group histiocytoses
Roei Mazor, MDEfficacy of Dual BRAF/MAP2K1 Blockade in BRAF mutant Erdheim Chester Disease PatientsNo Videos available
Skand Shekhar, MDHypothyroidism in Erdheim-Chester Disease: Experience from the National Institutes of HealthNo Videos available
Gordon Ruan, MDAcute Pancreatitis from treatment with BRAF-inhibitors in patients with Erdheim-Chester DiseaseAcute Pancreatitis from treatment with BRAF-inhibitors in patients with Erdheim-Chester Disease
Eli L. Diamond, MDPanel Discussion: TOXICITY OF ECD THERAPIESNo Videos available
Julio Hajdenberg, MDPanel Discussion: COMPLEX CASE STUDIESNo Videos available
Kathleen BrewerECDGA AnnouncementsNo Videos available

Fotografier

Medisinsk symposium

Medisinsk møte